Surgalign Holdings (Surgalign Holdings) Cash-to-Debt : 2.19 (As of Mar. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Surgalign Holdings Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. Surgalign Holdings's cash to debt ratio for the quarter that ended in Mar. 2023 was 2.19.

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. Here we can see, Surgalign Holdings could pay off its debt using the cash in hand for the quarter that ended in Mar. 2023.

The historical rank and industry rank for Surgalign Holdings's Cash-to-Debt or its related term are showing as below:

SRGAQ' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01 Med: 0.22 Max: No Debt
Current: 2.19

During the past 13 years, Surgalign Holdings's highest Cash to Debt Ratio was No Debt. The lowest was 0.01. And the median was 0.22.

SRGAQ's Cash-to-Debt is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 2.03 vs SRGAQ: 2.19

Surgalign Holdings Cash-to-Debt Historical Data

The historical data trend for Surgalign Holdings's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Surgalign Holdings Cash-to-Debt Chart

Surgalign Holdings Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Cash-to-Debt

Get a 7-Day Free Trial

0.22

5.80

No Debt

5.14

1.60

Surgalign Holdings Quarterly Data
	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Cash-to-Debt	Get a 7-Day Free Trial															4.45	2.91	1.37	1.60	2.19

Competitive Comparison of Surgalign Holdings's Cash-to-Debt

For the Medical Devices subindustry, Surgalign Holdings's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Surgalign Holdings's Cash-to-Debt Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Surgalign Holdings's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where Surgalign Holdings's Cash-to-Debt falls into.

Surgalign Holdings Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

Surgalign Holdings's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	16.295	/	(0	+	10.192)
	=	1.60

Surgalign Holdings's Cash to Debt Ratio for the quarter that ended in Mar. 2023 is calculated as:

Cash to Debt Ratio	=	Cash, Cash Equivalents, Marketable Securities	/	Total Debt
	=	Cash, Cash Equivalents, Marketable Securities	/	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)
	=	22.43	/	(0	+	10.244)
	=	2.19

Surgalign Holdings (OTCPK:SRGAQ) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.

Surgalign Holdings Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of Surgalign Holdings's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Surgalign Holdings (Surgalign Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Surgalign Holdings Inc (OTCPK:SRGAQ) » Definitions » Cash-to-Debt

Comparable Companies

Traded in Other Exchanges

N/A

Address

520 Lake Cook Road, Suite 315, Deerfield, IL, USA, 60015

Website

https://www.surgalign.com

Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.

Executives

Elizabeth A. Lapuma	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Jill Kathleen Frizzley	director	P.O. BOX 1541, ONE BLUE HILL PLAZA, PEARL RIVER NY 10965
Paolo Amoruso	officer: Chief Legal Officer	C/O HYPERDYNAMICS CORPORATION, 12012 WICKCHESTER LANE, SUITE 475, HOUSTON TX 77079
David Lyle	officer: Chief Financial Officer	6290 SEQUENCE DRIVE, SAN DIEGO CA 92121
Marc E. Mackey	officer: EVP, Digital Surgery	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Terry M. Rich	officer: President, Global Spine	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
William Scott Durall	officer: Chief Commercial Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Christopher Thunander	officer: Chief Accounting Officer	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Thomas Mceachin	director	11621 RESEARCH CIRCLE, ALACHUA FL 32615
Nicholas J Valeriani	director	C/O EDWARDS LIFESCIENCES CORPORATION, ONE EDWARDS WAY, IRVINE CA 92614
Sheryl L Conley	director	C/O NEURONETICS, INC., 3222 PHOENIXVILLE PIKE, MALVERN PA 19355
Enrico Sangiorgio	officer: EVP, International	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Stuart F. Simpson	director	520 LAKE COOK ROAD, SUITE 315, DEERFIELD IL 60015
Pawel Lewicki	director	296 WOODWARD BLVD., TULSA OK 74114
Jeffrey C Lightcap	director	152 W 57TH STREET 43RD FLOOR, NEW YORK NY 10019